期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (1)
Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent syndrome with high cardiovascular and non-cardiovascular morbidity......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (2)
Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological entity linked to multiple aetiologies with similar neuroimaging fin......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (3)
Hypertension (HYP) is the first cause of death and disability worldwide. In Spain, one in 3 adults was hypertensive in 2010 (62% in those >65 years......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (2)
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease Prevention. We p......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (1)
Ambulatory blood pressure monitoring (ABPM) is a basic toot in the diagnosis and treatment of hypertension (HT). Validity is based on the number of re......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (1)
Secondary arterial hypertension (HTN) can be caused by primary hyperaldosteronism, renovascular disease, sleep apnea syndrome, chronic kidney disease,......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (2)
Introduction: Hypertension (HTN) is the leading cause of mortality and disability in the world. In Argentina, almost 44% of hypertensives do not know ......
期刊： HIPERTENSION Y RIESGO VASCULAR, 2022; 39 (2)
Information and communication technology (ICT) have advanced remarkably in recent years. In the field of medicine, the problem of hypertension managem......
